Literature DB >> 11219791

A short history of vaccination in Australia.

H F Gidding1, M A Burgess, A E Kempe.   

Abstract

It is almost 50 years since infant vaccination for diphtheria, pertussis and tetanus became routine in Australia. Since then, the incidence of vaccine-preventable diseases has declined dramatically. We have used existing records and the recollections of experts to compile a history of vaccination in Australia, focusing on vaccines in the current childhood schedule.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11219791     DOI: 10.5694/j.1326-5377.2001.tb143144.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

1.  Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus.

Authors:  J L Backhouse; H F Gidding; P B McIntyre; G L Gilbert
Journal:  Clin Vaccine Immunol       Date:  2006-07

2.  Elimination of endemic measles transmission in Australia.

Authors:  Anita E Heywood; Heather F Gidding; Michaela A Riddell; Peter B McIntyre; C Raina MacIntyre; Heath A Kelly
Journal:  Bull World Health Organ       Date:  2009-01       Impact factor: 9.408

3.  The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia.

Authors:  Helen E Quinn; Peter B McIntyre
Journal:  Bull World Health Organ       Date:  2011-07-05       Impact factor: 9.408

4.  Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine.

Authors:  Julianne Bayliss; Michael Nissen; Damita Prakash; Peter Richmond; Kyu-Bin Oh; Terry Nolan
Journal:  Hum Vaccin Immunother       Date:  2020-06-23       Impact factor: 3.452

5.  Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign.

Authors:  Heath A Kelly; Heather F Gidding; Theo Karapanagiotidis; Jennie A Leydon; Michaela A Riddell
Journal:  BMC Public Health       Date:  2007-06-08       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.